Poolbeg Pharma PLC Ordinary Shares (POLB)

Industry Biotechnology


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

3.60p

Buy

4.10p

arrow-down-0.05p (-1.35%)

Prices updated at 16 Dec 2025, 12:42 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Sector
Healthcare
Industry
Biotechnology
Chairman
Mr. Cathal Martin Friel
CEO
Dr. Jeremy Skillington
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
10
Head office
42 New Road
London
United Kingdom
E1 2AX
mobile
+44 2071831499
letter
info@poolbegpharma.com

Key personnel

Salary
Professor Brendan Buckley
Non-Executive Director
-
Mr. Ian O'Connell
Executive Director, Chief Financial Officer
-
Dr. Jeremy Skillington
Executive Director, Chief Executive Officer
-
Mr. Cathal Martin Friel
Executive Director, Chairman
-

Top 5 shareholders

No. of shares
YFS Sterling Select Companies Fd5,042,590

Director dealings

Action
25 Jun 2025Purchase
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.